CAS 969-99-3: Chlorpromazine sulfoxide
Formula:C17H19ClN2OS
InChI:InChI=1S/C17H19ClN2OS/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)22(21)17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3
InChI key:InChIKey=QEPPAOXKZOTMPM-UHFFFAOYSA-N
SMILES:C(CCN(C)C)N1C=2C(S(=O)C=3C1=CC=CC3)=CC=C(Cl)C2
Synonyms:- 10-(g-Dimethylaminopropyl)-3-chlorphenothiazine 9-Oxide
- 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, 5-oxide (9CI)
- 10H-phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, 5-oxide
- 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine 5-Oxide
- 2-Chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine 5-Oxide
- Aminazin sulfoxide
- Ba 2835
- Chlorpromazine 5-oxide
- Chlorpromazine 5-sulfoxide
- Chlorpromazine S-oxide
- Chlorpromazine sulfoxide
- See more synonyms
Sort by
Found 10 products.
Chlorpromazine EP Impurity A (Chlorpromazine Sulfoxide)
CAS:Formula:C17H19ClN2OSColor and Shape:White To Off-White SolidMolecular weight:334.86Chlorpromazine Sulfoxide
CAS:Chlorpromazine Sulfoxide is a photochemical degradation product of chlorpromazine. It has been shown to inhibit the replication of the human immunodeficiency virus (HIV) in human serum and human polymorphonuclear leukocytes (PMNLs). Chlorpromazine Sulfoxide inhibits the activity of nucleotide levels by binding to them, preventing their incorporation into DNA and RNA. In addition, it also inhibits PMNL migration and induces apoptosis in squamous carcinoma cells.Formula:C17H19ClN2OSPurity:Min. 95%Molecular weight:334.86 g/mol3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine S-Oxide (Chlorpromazine Sulfoxide)
CAS:Controlled ProductFormula:C17H19ClN2OSColor and Shape:NeatMolecular weight:334.86Chlorpromazine sulfoxide
CAS:Chlorpromazine sulfoxideFormula:C17H19ClN2OSColor and Shape:Light YellowMolecular weight:334.8636Chlorpromazine Sulfoxide
CAS:Impurity Chlorpromazine EP Impurity A Applications Chlorpromazine Sulfoxide is a derivative of Chlorpromazine Hydrochloride (C424750), which is a dopamine antagonist of the typical antipsychotic class of medications possessing additional antiadrenergic, antiserotonergic, anticholinergic and antihistaminergic properties used for schizophrenia treatment. References Anden, N.-E., et al.: Eur. J. Pharmacol., 11, 303 (1970), Curzon, G., et al.: Trends Pharmacol. Sci., 11, 61 (1990), Yuhas, D., Svi. Smer. Mind, (March 2003),Formula:C17H19ClN2OSColor and Shape:Light YellowMolecular weight:334.86
